An official website of the United States government
Enable large international collaborations aimed at overcoming barriers to sharing of human data (genetic and other data types).
2030 RFA-AG-24-027: Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) RFA-AG-25-007: Centers on the Demography and Economics of Aging and Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (P30 Clinical Trial Optional) RFA-AG-25-008: Centers on the Demography and Economics of Aging and Alzheimer’s Disease and Alzheimer’s Disease Related Dementias Coordinating Center (U24 Clinical Trial Optional) 14.P In Progress Large international collaborations aimed at overcoming barriers to sharing of human data DN 2021 AD Summit: 2.F Blog: Apply by Feb. 14: Funding to expand Alzheimer’s research infrastructure in Africa Public Private Partnerships 2024
- Establish a global initiative to facilitate the sharing of human data and removing barriers due to different data sharing policies/restrictions.
Summary of Key Accomplishments
NIA launched the Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa. Through this initiative, NIA supports 1) transformative collaborations between scientists and institutions in the United States and low- and middle-income countries in Africa; 2) research on how social or behavioral factors influence AD/ADRD in Africa; and 3) pilot or exploratory studies to inform future research for AD/ADRD neuroscience in Africa. By supporting the development of research infrastructure in Africa, NIA expects to contribute to building sustainable AD/ADRD neuroscience research capacity and research that will result in prevention and mitigation strategies for AD/ADRD in Africa. Current research includes an intervention that uses a portable low-field brain magnetic resonance imaging for ADRD in a rural community; the creation of tools for dementia diagnostics and identification of region-specific determinants of cognitive impairment and decline; and research to improve dementia screening, diagnosis and care.
The key accomplishments summary is current as of September 2025.